Tägliche HNO-Überweisung: Einseitige Nasenatmungsbehinderung und Cephalgien

Schlüsselwörter

Kopf-Hals-Chirurgie - Tumorchirurgie - NUT-Karzinom - Plattenepithelkarzinom - Nasenatmungsbehinderung - Rare tumors - NUT midline carcinoma - Squamous cell carcinoma

Publikationsverlauf

Eingereicht: 24. Januar 2021

Angenommen nach Revision: 20. Juli 2021

Artikel online veröffentlicht:
27. August 2021

• Literatur

• 1 Hellquist H. et al. NUT midline carcinoma of the larynx: An international series and review of the literature. Histopathology 2017; 70 (06) 861-868
• 2 Bishop JA, Westra WH. NUT Midline Carcinomas of the Sinonasal Tract; Am. J Surg Pathol 2012; 36 (08) 1216-1221
• 3 Edgar M, Caruso AM, Kim E. et al. NUT Midline Carcinoma of the Nasal Cavity. Head Neck Pathol 2017; 11 (03) 389-392
• 4 Robin MD. et al. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer 2017;
• 5 Lopez F, Suárez V, Vivanco B, Suárez C, Llorente JL. Current management of sinonasal undifferentiated carcinoma. Rhinology 2015; 53 (03) 212-220
• 6 Engleson J, Soller M, Panagopoulos I. et al. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy, BMC Cancer. 2006; 6: 69
• 7 Baumgartner K, Lauer U, Horger M. et al. Nuclear-protein-in-testis (NUT)-Mittellinienkarzinom. Rofo 2020; 192 (04) 303-306
• 8 Haack H. et al. Diagnosis of NUT Midline Carcinoma Using a NUT-Specific Monoclonal Antibody. Am J Surg Pathol 2009; 33 (07) 984-991